Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

Global Health Limited's projected revenue decline from last year is likely to make investors cautious. Lower revenues often hurt a company's bottom line, leading investors to be concerned about the company's ability to maintain profitability and deliver strong financial results in the future.

Financial Ratios:

currentRatio 0.000000
forwardPE 52.124157
debtToEquity 21.907000
earningsGrowth 0.157000
revenueGrowth 0.133000
grossMargins 0.514730
operatingMargins 0.200670
trailingEps 18.840000
forwardEps 23.410000

MEDANTA's high forward PE ratio signals potential overvaluation, limiting further price gains and increasing the risk of a correction. This metric should be carefully considered alongside other key fundamentals to assess the stock's future performance.
MEDANTA's low Debt-to-Equity ratio reflects that the company isn't heavily reliant on debt, reducing financial risk. This conservative approach suggests MEDANTA maintains a stable financial foundation, with greater flexibility to manage future growth or challenges without over-leverage concerns.
MEDANTA's positive earnings and revenue growth indicate that the company is expected to continue expanding its business. These trends reflect strong financial health, with increasing profits and sales suggesting sustained growth and success for MEDANTA.
MEDANTA's positive gross and operating margins indicate a profitable and efficient business model. These metrics highlight the company's ability to generate income while controlling operational costs, reflecting strong financial performance.
MEDANTA's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting MEDANTA to generate stronger earnings compared to the previous financial year.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

The stock price of Global Health Limited has often been near the lower end of projections, indicating that it may not be meeting investor expectations. This trend could suggest challenges ahead for the company.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


Analysts have been favoring MEDANTA with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning MEDANTA as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.